Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells

• Published in: Pathology oncology research 2021-03, Vol.27, p.581395-581395
• Main Authors: Kiss, Tímea, Jámbor, Krisztina, Koroknai, Viktória, Szász, István, Bárdos, Helga, Mokánszki, Attila, Ádány, Róza, Balázs, Margit
• Format: Article
• Language: English
• Subjects: Cell growth; Cell Line, Tumor; Cell Movement - genetics; Cell Proliferation - genetics; Drug development; Experiments; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanoma; Melanoma - genetics; Melanoma - metabolism; Melanoma - pathology; Metastasis; Osteopontin - genetics; Osteopontin - metabolism; Pathology & Oncology Research; Protein expression; Protein Interaction Maps; Proteins; Reagents; RNA, Small Interfering - genetics; Signal Transduction - genetics; Skin cancer; Software; Statistical analysis; Tumors
• ISSN: 1532-2807; 1219-4956; 1532-2807
• DOI: 10.3389/pore.2021.581395

Osteopontin (OPN) is a multifunctional phosphoprotein that is expressed in different types of cancers, including melanoma. OPN overexpression is associated with tumor progression and metastasis formation; however, the role of OPN in cell invasion and metastasis formation is not completely understood. In this study we aimed to define OPN expression in melanoma tissues and cell lines and investigate the effect of OPN expression on cell proliferation and invasion after inhibiting OPN expression with small interfering RNA (siRNA). OPN gene expression was determined by qRT-PCR, while protein expression was examined using a Proteome Profiler Oncology Array. siRNA-mediated OPN knockdown led to decreased OPN expression in melanoma cell lines, which was associated with decreased cell proliferation and invasion. Proteome profile analysis revealed significantly different protein expression between the original and transfected cell lines. The altered expression of the differently expressed proteins was validated at the mRNA level. Furthermore, OPN-specific siRNA was able to reduce OPN expression and inhibit the invasiveness of melanoma cells. Our results revealed for the first time that silencing the OPN gene influences proliferation and invasion of melanoma cells by effecting EGFR, tenascin C, survivin, galectin-3 and enolase 2 expression. To predict protein-protein interactions along with putative pathways we used STRING analysis for the differentially expressed proteins. These proteins formed multiple clusters, including extracellular matrix organization, regulation of angiogenesis, cell death and cell migration, PI3K-Akt, MAPK and focal adhesion signaling pathways. Taken together these data suggest that OPN might be an ideal target for drug development and therapies.